97 related articles for article (PubMed ID: 7836494)
1. High false alarm rates on a vigilance task may indicate recreational drug use.
Damos DL; Parker ES
J Clin Exp Neuropsychol; 1994 Oct; 16(5):713-22. PubMed ID: 7836494
[TBL] [Abstract][Full Text] [Related]
2. Application of human laboratory data for the assessment of performance in workplace settings: practical and theoretical considerations.
Heishman SJ; Henningfield JE
NIDA Res Monogr; 1990; 100():167-74. PubMed ID: 2132770
[No Abstract] [Full Text] [Related]
3. Neuropsychological impairment and gender differences in HIV-1 infection.
Faílde-Garrido JM; Alvarez MR; Simón-López MA
Psychiatry Clin Neurosci; 2008 Oct; 62(5):494-502. PubMed ID: 18950367
[TBL] [Abstract][Full Text] [Related]
4. Development of repeated acquisition methodologies: implications for the detection of drug-induced disruption in human learning.
Bickel WK; Higgins ST; Hughes JR
NIDA Res Monogr; 1990; 100():99-111. PubMed ID: 2132780
[No Abstract] [Full Text] [Related]
5. Comparative drug effects and abuse liability of lorazepam, buspirone, and secobarbital in nondependent subjects.
Sellers EM; Schneiderman JF; Romach MK; Kaplan HL; Somer GR
J Clin Psychopharmacol; 1992 Apr; 12(2):79-85. PubMed ID: 1573044
[TBL] [Abstract][Full Text] [Related]
6. Drug performance sensitivity: a pilot study.
Moskowitz H; Chen D
J Clin Psychopharmacol; 1990 Aug; 10(4 Suppl):20S-23S. PubMed ID: 2229458
[TBL] [Abstract][Full Text] [Related]
7. Information processing and antiretroviral therapy in HIV-1 infection.
Martin EM; Pitrak DL; Pursell KJ; Andersen BR; Mullane KM; Novak RM
J Int Neuropsychol Soc; 1998 Jul; 4(4):329-35. PubMed ID: 9656606
[TBL] [Abstract][Full Text] [Related]
8. Neuropsychological assessment in behavioral toxicology--developing techniques and interpretative issues.
Lezak MD
Scand J Work Environ Health; 1984; 10 Suppl 1():25-9. PubMed ID: 6494852
[No Abstract] [Full Text] [Related]
9. Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.
Indlekofer F; Piechatzek M; Daamen M; Glasmacher C; Lieb R; Pfister H; Tucha O; Lange KW; Wittchen HU; Schütz CG
J Psychopharmacol; 2009 Jul; 23(5):495-509. PubMed ID: 18635709
[TBL] [Abstract][Full Text] [Related]
10. Effects of immunosuppression and disease severity upon neuropsychological function in HIV infection.
Basso MR; Bornstein RA
J Clin Exp Neuropsychol; 2000 Feb; 22(1):104-14. PubMed ID: 10649549
[TBL] [Abstract][Full Text] [Related]
11. Assessment of AIDS-related cognitive changes: recommendations of the NIMH Workshop on Neuropsychological Assessment Approaches.
Butters N; Grant I; Haxby J; Judd LL; Martin A; McClelland J; Pequegnat W; Schacter D; Stover E
J Clin Exp Neuropsychol; 1990 Dec; 12(6):963-78. PubMed ID: 2286659
[TBL] [Abstract][Full Text] [Related]
12. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
Reay JL; Hamilton C; Kennedy DO; Scholey AB
J Psychopharmacol; 2006 May; 20(3):385-8. PubMed ID: 16574712
[TBL] [Abstract][Full Text] [Related]
13. Real-time performance modelling of a Sustained Attention to Response Task.
Larue GS; Rakotonirainy A; Pettitt AN
Ergonomics; 2010 Oct; 53(10):1205-16. PubMed ID: 20865604
[TBL] [Abstract][Full Text] [Related]
14. A study investigating the acute dose-response effects of 13 mg and 17 mg Delta 9- tetrahydrocannabinol on cognitive-motor skills, subjective and autonomic measures in regular users of marijuana.
Weinstein A; Brickner O; Lerman H; Greemland M; Bloch M; Lester H; Chisin R; Sarne Y; Mechoulam R; Bar-Hamburger R; Freedman N; Even-Sapir E
J Psychopharmacol; 2008 Jun; 22(4):441-51. PubMed ID: 18635724
[TBL] [Abstract][Full Text] [Related]
15. The effects of alcohol and other drugs on psychomotor performance and cognitive function.
Hindmarch I; Kerr JS; Sherwood N
Alcohol Alcohol; 1991; 26(1):71-9. PubMed ID: 1854375
[TBL] [Abstract][Full Text] [Related]
16. Recognition and treatment of substance abuse in the elderly.
Thibault JM; Maly RC
Prim Care; 1993 Mar; 20(1):155-65. PubMed ID: 8464937
[TBL] [Abstract][Full Text] [Related]
17. Working memory in individuals with HIV infection.
Law WA; Martin A; Mapou RL; Roller TL; Salazar AM; Temoshok LR; Rundell JR
J Clin Exp Neuropsychol; 1994 Apr; 16(2):173-82. PubMed ID: 8021304
[TBL] [Abstract][Full Text] [Related]
18. Working memory and depressive symptoms in patients with schizophrenia and substance use disorders.
Potvin S; Pampoulova T; Lipp O; Ait Bentaleb L; Lalonde P; Stip E
Cogn Neuropsychiatry; 2008 Jul; 13(4):357-66. PubMed ID: 18622790
[TBL] [Abstract][Full Text] [Related]
19. Sleep loss affects vigilance: effects of chronic insomnia and sleep therapy.
Altena E; Van Der Werf YD; Strijers RL; Van Someren EJ
J Sleep Res; 2008 Sep; 17(3):335-43. PubMed ID: 18844819
[TBL] [Abstract][Full Text] [Related]
20. Slowed information processing in HIV-1 disease. The Multicenter AIDS Cohort Study (MACS).
Llorente AM; Miller EN; D'Elia LF; Selnes OA; Wesch J; Becker JT; Satz P
J Clin Exp Neuropsychol; 1998 Feb; 20(1):60-72. PubMed ID: 9672820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
